Faecal microbiota transplantation for inflammatory bowel disease: A systematic review and meta-analysis

Journal of Crohn's and Colitis

Volumn 11, Issue 10, 2017, Pages 1180-1199

  Paramsothy, Sudarshan ^a,b   Paramsothy, Ramesh ^c   Rubin, David T ^a   Kamm, Michael A ^d   Kaakoush, Nadeem O ^b   Mitchell, Hazel M ^b   Castaño Rodríguez, Natalia ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c LIVERPOOL HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Crohn's disease; Faecal microbiota transplantation; Inflammatory bowel disease; Meta analysis; Pouchitis; Systematic review; Ulcerative colitis

Indexed keywords

ABDOMINAL CRAMP; ABDOMINAL PAIN; ARTICLE; ASPIRATION PNEUMONIA; BLOATING; BORBORYGMUS; CLINICAL EFFECTIVENESS; CROHN DISEASE; DIARRHEA; FECAL MICROBIOTA TRANSPLANTATION; FEVER; FLATULENCE; GASTROINTESTINAL SYMPTOM; HUMAN; ILEITIS; INFLAMMATORY BOWEL DISEASE; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; REMISSION; SEPSIS; SYSTEMATIC REVIEW; TOXIC MEGACOLON; TREATMENT RESPONSE; ULCERATIVE COLITIS; INTESTINE FLORA; TREATMENT OUTCOME;

COLITIS, ULCERATIVE; CROHN DISEASE; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; TREATMENT OUTCOME;

EID: 85026871259     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjx063     Document Type: Article

References (77)

1. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368:407-15
2. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013;108:500-8
3. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2011;9:88-96
4. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958;44:854-9
5. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989;1:164
6. Smith MB, Kelly C, Alm EJ. Policy: How to regulate faecal transplants. Nature 2014;506:290-1
7. Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012;36:503-16
8. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 2014;8:1569-81
9. Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 2015;149:102-9 e6
10. Rossen NG, Fuentes S, van der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 2015;149:110-8.e4
11. Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 2017;389:1218-28
12. Costello S, Waters O, Bryant R, et al. Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mildmoderately active ulcerative colitis: a randomised controlled trial. In: 12th Congress of ECCO; February 15-18, 2017; Barcelona, Spain
13. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535
14. Furlan AD, Pennick V, Bombardier C, van Tulder M; Editorial Board, Cochrane Back Review Group. 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 2009;34:1929-41
15. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology [MOOSE] group. JAMA 2000;283:2008-12
16. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale [NOS] for assessing the quality of nonrandomised studies in meta-analyses. Volume 2017. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed March 1, 2017
17. Higgins JP, Altman DG, Gøtzsche PC, et al.; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58
19. Borody TJ, George L, Andrews P, et al. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989;150:604
20. Borody T, Campbell J, Torres M, et al. Reversal of idiopathic thrombocytopenic purpura [ITP] with fecal microbiota transplantation [FMT]. Am J Gastroenterol 2011;106:S352
21. Hohmann EL, Ananthakrishnan AN, Deshpande V. Case Records of the Massachusetts General Hospital. Case 25-2014. A 37-year-old man with ulcerative colitis and bloody diarrhea. N Engl J Med 2014;371:668-75
22. Vandenplas Y, Veereman G, van der Werff Ten Bosch J, et al. Fecal microbial transplantation in early-onset colitis: caution advised. J Pediatr Gastroenterol Nutr 2015;61:e12-4
23. Seth AK, Rawal P, Bagga R, Jain P. Successful colonoscopic fecal microbiota transplantation for active ulcerative colitis: First report from India. Indian J Gastroenterol 2016;35:393-5
24. Kumagai H, Yokoyama K, Imagawa T, et al. Failure of fecal microbiota transplantation in a three-year-old child with severe refractory ulcerative colitis. Pediatr Gastroenterol Hepatol Nutr 2016;19:214-20
25. Ni X, Fan S, Zhang Y, et al. Coordinated hospital-home fecal microbiota transplantation via percutaneous endoscopic cecostomy for recurrent steroid-dependent ulcerative colitis. Gut Liver 2016;10:975-80
26. Shimizu H, Arai K, Abe J, et al. Repeated fecal microbiota transplantation in a child with ulcerative colitis. Pediatr Int 2016;58:781-5
27. Borody T, Leis S, McGrath K, et al. Treatment of chronic constipation and colitis using human probiotic infusions. In: Probiotics, Prebiotics and New Foods Conference; September 2-4, 2001; Rome: Universita Urbaniana
28. Borody TJ, Warren EF, Leis S, Surace R, Ashman O. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003;37:42-7
29. Borody T, Wettstein A, Campbell J, et al. Fecal microbiota transplantation in ulcerative colitis: Review of 24 years experience. Am J Gastroenterol 2012;107:S665
30. Shah R, Robinson L, Herrera HR, et al. Human probiotic infusion [HPI] in ulcerative colitis-'patient's perceptions and predictors of efficacy'. Gastroenterology 2012;142:S253
31. Brandt L, Aroniadis O, Greenberg A, et al. Safety of fecal microbiota transplantation [FMT] in immunocompromised [IC] patients with inflammatory bowel disease [IBD]. Am J Gastroenterol 2013;108:S556
32. Angelberger S, Reinisch W, Makristathis A, et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013;108:1620-30
33. Kump PK, Gröchenig HP, Lackner S, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 2013;19:2155-65
34. Kunde S, Pham A, Bonczyk S, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013;56:597-601
35. Cui B, Li P, Xu L, et al. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med 2015;13:298
36. Damman CJ, Brittnacher MJ, Westerhoff M, et al. Low level engraftment and improvement following a single colonoscopic administration of fecal microbiota to patients with ulcerative colitis. PLoS One 2015;10:e0133925
37. Karolewska-Bochenek K, Lazowska-Przeorek I, Grzesiowski P, et al. Fecal microbiota transplantation in refractory pediatric UC-Preliminary data. J Crohns Colitis 2015;9:S294
38. Kellermayer R, Nagy-Szakal D, Harris RA, et al. Serial fecal microbiota transplantation alters mucosal gene expression in pediatric ulcerative colitis. Am J Gastroenterol 2015;110:604-6
39. Kump PK, Wurm P, Gröchenig HP, et al. Impact of antibiotic treatment before faecal microbiota transplantation [FMT] in chronic active ulcerative colitis. United European Gastroenterol J 2015;3(5 Suppl):A437
40. Scaldaferri F, Pecere S, Bruno G, et al. An open-label, pilot study to assess feasibility and safety of fecal microbiota transplantation in patients with mild-moderate ulcerative colitis: Preliminary results. J Crohns Colitis 2015;9:S278
41. Suskind DL, Singh N, Nielson H, Wahbeh G. Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr 2015;60:27-9
42. Vermeire S, Joossens M, Verbeke K, et al. Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J Crohns Colitis 2016;10:387-94
43. Wei Y, Zhu W, Gong J, et al. Fecal microbiota transplantation improves the quality of life in patients with inflammatory bowel disease. Gastroenterol Res Pract 2015;2015:517597
44. Ren R, Sun G, Yang Y, et al. [A pilot study of treating ulcerative colitis with fecal microbiota transplantation]. Zhonghua Nei Ke Za Zhi 2015;54:411-5
45. Karakan T, Ibis M, Cindoruk Z, et al. Faecal microbiota transplantation as a rescue therapy for steroid-dependent and/or non-responsive patients with ulcerative colitis: a pilot study. In: 11th Congress of the European Crohn's and Colitis Organisation, March 16-19, 2016; Amsterdam, The Netherlands
46. Goyal A, Chu A, Calabro K, et al. Safety and efficacy of fecal microbiota transplant in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2016;63:S212
47. Laszlo M, Ciobanu L, Andreica V, Pascu O. Fecal transplantation indications in ulcerative colitis. Preliminary study. Clujul Med 2016;89:224-8
48. Wei Y, Gong J, Zhu W, et al. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora. BMC Microbiol 2016;16:255
49. Pai N, Popov J, Lee C. A randomized, placebo-controlled trial of fecal microbial transplantation for pediatric ulcerative colitis [Pedifetch Trial]. J Pediatr Gastroenterol Nutr 2016;63:S79-80
50. Jacob V, Crawford C, Cohen-Mekelburg S, et al. Fecal microbiota transplantation via colonoscopy is safe and effective in active ulcerative colitis. In: Advances in Inflammatory Bowel Diseases; December 8-10, 2016; Orlando, FL
51. Nishida A, Imaeda H, Ohno M, et al. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis. J Gastroenterol 2017;52:476-82
52. Zhang T, Cui B, Li P, et al. Short-term surveillance of cytokines and C-reactive protein cannot predict efficacy of fecal microbiota transplantation for ulcerative colitis. PLoS One 2016;11:e0158227
53. Grewal CS, Sood A, Mehta V, et al. Role of fecal microbiota transplantation in patients with steroid dependant ulcerative colitis. Am J Gastroenterol 2016;111:S1252-3
54. Ishikawa D, Sasaki T, Osada T, et al. Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis. Inflamm Bowel Dis 2017;23:116-25
55. Swaminath A. The power of poop: patients getting ahead of their doctors using self-administered fecal transplants. Am J Gastroenterol 2014;109:777-8
56. Gordon H, Harbord M. A patient with severe Crohn's colitis responds to faecal microbiota transplantation. J Crohns Colitis 2014;8:256-7
57. Kao D, Hotte N, Gillevet P, Madsen K. Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile. J Clin Gastroenterol 2014;48:625-8
58. Kahn SA, Goeppinger SR, Vaughn BP, et al. Tolerability of colonoscopic fecal microbiota transplantation in IBD. Gastroenterology 2014;146:S-581
59. Cui B, Feng Q, Wang H, et al. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol 2015;30:51-8
60. Suskind DL, Brittnacher MJ, Wahbeh G, et al. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease. Inflamm Bowel Dis 2015;21:556-63
61. Vaughn BP, Vatanen T, Allegretti JR, et al. Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn's disease. Inflamm Bowel Dis 2016;22:2182-90
62. Fang S, Kraft CS, Dhere T, et al. Successful treatment of chronic pouchitis utilizing fecal microbiota transplantation [FMT]: a case report. Int J Colorectal Dis 2016;31:1093-4
63. Landy J, Walker AW, Li JV, et al. Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis. Sci Rep 2015;5:12955
64. El-Nachef N, Lucey K, Somsouk M, et al. Fecal microbiota transplant improves symptoms in patients with pouchitis and induces changes in the microbiome: Preliminary results of an open label trial. Gastroenterology 2016;150:S544
65. Stallmach A, Lange K, Buening J, Sina C, Vital M, Pieper DH. Fecal microbiota transfer in patients with chronic antibiotic-refractory pouchitis. Am J Gastroenterol 2016;111:441-3
66. Paramsothy S, Kaakoush N, Kamm MA, et al. Faecal microbiota transplantation [FMT] in ulcerative colitis [UC] is associated with specific bacterial changes: Stool and colonic mucosa 16S microbiota analysis from the randomised controlled FOCUS Study. In: United European Gastroenterology Week; October 1519, 2016; Vienna
67. Fuentes S, Rossen NG, van der Spek MJ, et al. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation. ISME J 2017, Apr 11. doi: 10.1038/ismej.2017.44. [Epub ahead of print.]
68. Kump PK, Wurm P, Grochenig HP, et al. Clinical response to fecal microbiota transplantation in chronic active ulcerative colitis depends on the taxonomic composition of the donor microbiota. In: United European Gastroenterology Week; October 1519, 2016; Vienna
69. Rossen NG, MacDonald JK, de Vries EM, et al. Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. World J Gastroenterol 2015;21:5359-71
70. Sha S, Liang J, Chen M, et al. Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment Pharmacol Ther 2014;39:1003-32
71. König J, Siebenhaar A, Högenauer C, et al. Consensus report: faecal microbiota transfer clinical applications and procedures. Aliment Pharmacol Ther 2017;45:222-39
72. Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017;66:569-80
73. Feagan BG, Rutgeerts P, Sands BE, et al.; GEMINI 1 Study Group. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2013;369:699-710
74. Sandborn WJ, Ghosh S, Panes J, et al.; Study A3921063 Investigators. Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. N Engl J Med 2012;367:616-24
75. Sandborn WJ, Feagan BG, Wolf DC, et al.; TOUCHSTONE Study Group. Ozanimod induction and maintenance treatment for ulcerative colitis. N Engl J Med 2016;374:1754-62
76. Khoruts A, Rank KM, Newman KM, et al. Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 2016;14:1433-8
77. Fischer M, Kao D, Kelly C, et al. Fecal microbiota transplantation is safe and efficacious for recurrent or refractory clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis 2016;22:2402-9